Eosinophilic Gastroenteritis
Section snippets
Epidemiology
Because of a notable scarcity of published data on the epidemiology, it is difficult to determine the true burden of EG. An English language literature review does not reveal a well-analyzed published case series describing primary EG in the last 3 years, suggesting that it is an uncommon and perhaps difficult-to-diagnose disorder. Nevertheless, several case reports of EG have emerged recently in different parts of the world [1], [2], [3], [4], [5]. The diagnosis affects most ethnicities, and
Pathogenesis
EG may be primary, also known as allergic, or secondary to one of many conditions that provoke eosinophilic inflammation (see later section on differential diagnosis), with parasitic infections being the leading cause. The cause cannot be precisely determined in a small but important minority of patients, who are regarded as having idiopathic EG.
Clinical Presentations
Patients who have EG have heterogeneous clinical presentations, some of which overlap with more familiar diagnoses, such as functional GI disorders and inflammatory bowel disease. Presenting symptoms may be vague and nonspecific (eg, recurrent abdominal pain [23]) or dramatic (eg, gastric ulcer perforation [24]). Symptom onset may be at any age, but most patients are diagnosed as young adults, between the third and fifth decades of life. Often patients experience symptoms for many months and
Differential Diagnosis
A broad range of conditions are associated with gastrointestinal mucosal eosinophilia and the following is a brief review of some of the important differential diagnoses.
Diagnostic Evaluation
Diagnosis of EG requires suspecting the disease, excluding other disorders in the differential diagnoses, confirming the definitive diagnosis, and assessing for potential complications. Currently accepted diagnostic criteria are the presence of gastrointestinal symptoms, an intense eosinophilic infiltrate on histopathologic examination, and exclusion of other causes of intestinal eosinophilia. Tests considered useful in the evaluation of EG and its differentials are presented in Table 1[62].
A
Management
Various treatments may be beneficial in EG [76]. Our current knowledge of the treatment of EG is derived virtually exclusively from small studies and anecdotal experience. Evidence for the true efficacy of any therapy suffers from the lack of well-designed and controlled studies. Nevertheless, corticosteroids and dietary therapy are two treatment interventions for which the data are convincingly favorable. Emerging treatments in development are biologics and selective anti-eosinophil agents.
Natural History
There is a dearth of information about the long-term course of patients who have treated or untreated EG. Most experts regard primary EG as a chronic disorder characterized by relapses and remissions, and hence the recommendations for close follow-up and perhaps repeated endoscopic surveillance in selected cases. The natural history of EG has not been well described, but clinical studies point to a chronic relapsing course for patients who have this diagnosis. The long-term follow-up (2.5 to
Summary
EG is an uncommon, yet important, entity in the spectrum of primary EGIDs, selectively affecting the stomach and small intestine with an eosinophilic inflammatory process. Multiple clinical presentations are recognized because of the variability in the location and depth of eosinophilic infiltration. History of atopy and allergies is present in 25% to 75% of cases. Recent investigations providing an insight into the pathogenesis of EG support a critical role for allergens, eosinophils,
References (90)
- et al.
Distinct clinical presentations of a single medical entity: eosinophilic enteritis
Gastroenterol Hepatol
(2007) Eosinophilic gastrointestinal disorders (EGID)
J Allergy Clin Immunol
(2004)- et al.
Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?
J Allergy Clin Immunol
(2007) - et al.
Activated eosinophils in familial eosinophilic gastroenteritis
Gastroenterology
(1985) - et al.
Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene
Gastroenterology
(2006) - et al.
Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry
J Pediatr
(2002) - et al.
[Gastrointestinal anisakiasis. Study of a series of 25 patients]
Gastroenterol Hepatol
(2003) - et al.
Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy?
Gastrointest Endosc
(2004) - et al.
Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps?
Hum Pathol
(2002) - et al.
Clinical overview of hypereosinophilic syndromes
Immunol Allergy Clin North Am
(2007)
Accuracy of IgE antibody laboratory results
Ann Allergy Asthma Immunol
Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents
J Allergy Clin Immunol
Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis
J Allergy Clin Immunol
Protein-losing enteropathy from eosinophilic enteritis diagnosed by wireless capsule endoscopy and double-balloon enteroscopy
Gastrointest Endosc
Eosinophilic jejunitis presenting with acute abdomen: the usefulness of double-balloon enteroscopy
Gastrointest Endosc
Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis
Clin Gastroenterol Hepatol
Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide
Dig Liver Dis
Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate
Gastroenterology
Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate
Gastrointest Endosc
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
J Allergy Clin Immunol
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
J Allergy Clin Immunol
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders
J Allergy Clin Immunol
Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders
Immunol Allergy Clin North Am
Verdict in the case of therapies versus eosinophils: the jury is still out
J Allergy Clin Immunol
Budesonide for the treatment of obstructive eosinophilic jejunitis
Z Gastroenterol
Eosinophilic enteritis presenting as intussusception in adult
Korean J Intern Med
Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature
World J Gastroenterol
Multiple exudative ulcers and pseudopolyps in allergic eosinophilic gastroenteritis that responded to dietary therapy
J Pediatr Gastroenterol Nutr
Eosinophilic gastroenteritis: clinical experience with 15 patients
World J Gastroenterol
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues
Gut
Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up
J Pediatr Gastroenterol Nutr
Eosinophilic gastroenteritis masquerading as pyloric stenosis
Clin Pediatr (Phila)
Eosinophilic gastroenteritis—an Indian experience
Indian J Gastroenterol
Eosinophilic gastroenteritis: 10 years experience
Am J Gastroenterol
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein
Clin Exp Immunol
Emerging questions regarding eosinophil's role in the esophago-gastrointestinal tract
Curr Opin Gastroenterol
Eosinophil function in eosinophil-associated gastrointestinal disorders
Curr Allergy Asthma Rep
Educational clinical case series in pediatric allergy and immunology
Pediatr Allergy Immunol
Eosinophilic gastroenteritis: a review
Dig Dis Sci
A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation
Nat Immunol
Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children
Acta Paediatr
Eosinophilic gastroenteritis presenting as acute gastric perforation
J Pediatr Gastroenterol Nutr
Eosinophilic gastroenteritis: our recent experience: one-year experience of atypical onset of an uncommon disease
Scand J Gastroenterol
Eosinophilic gastroenteritis
Scott Med J
Eosinophilic gastroenteritis
Medicine (Baltimore)
Cited by (86)
Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus
2018, The Lancet Gastroenterology and HepatologyClinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis
2015, Digestive and Liver DiseaseClinical and epidemiological characterization of eosinophilic ascites in Egypt: a single center experience
2024, Egyptian Liver JournalEosinophilic Gastroenteritis: Still a Diagnostic Challenge
2023, GE Portuguese Journal of GastroenterologyBenign Diseases of the Stomach
2022, Surgical Pathology of the Gastrointestinal System: Volume I-Gastrointestinal Tract